Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network-Reference-Cited by-同舟云学术

Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network

Published:2014-01 Issue:1 Volume:132 Page:181-187
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Maillet Denis,Goulvent Thibaut,Rimokh Ruth,Vacher-Lavenu Marie-Cecile,Pautier Patricia,Alexandre Jerome,Pujade-Laurraine Eric,Devouassoux-Shisheboran Mojgan,Treilleux Isabelle,Ray-Coquard Isabelle,Savina Ariel

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference27 articles.

1. Management of ovarian stromal cell tumors;Colombo;J Clin Oncol,2007

2. Clinical review of adult granulosa cell tumors of the ovary;Segal;Gynecol Oncol,1995

3. Pathology and classification of ovarian tumors;Chen;Cancer,2003

4. Ovarian sex cord stromal tumors a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry;Schneider;Virchows Arch,2003

5. Ovarian sex cord-stromal tumors in children and adolescents;Schneider;J Clin Oncol,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications;International Journal of Gynecological Pathology;2024-02-19

2. Molecular testing in gynecologic cancer;Diagnostic Molecular Pathology;2024

3. Relevance of Molecular Pathology for the Diagnosis of Sex Cord–Stromal Tumors of the Ovary: A Narrative Review;Cancers;2023-12-15

4. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study;Gynecologic Oncology;2023-07

5. Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03;Clinical and Translational Oncology;2023-01-28